At present 4 to 8% of the populationindustrialized countries suffers from bronchial asthma of varying severity. The increased incidence is related not only to environmental pollution but also less active lifestyle.
In Russia, according to various estimates, the prevalencein the adult population ranges from 3 to 7%, while the figure is about 10% among children. The disease can occur at any age; about half of patients with bronchial asthma developed before 10 years, one-third more - up to 40 years.
Among the factors in the development of asthmamany reasons: genetic predisposition, excessive irritability of bronchi; various external allergens, such as house dust, allergens, animals and insects, pollen; foods, drugs, various chemicals and aerosols, respiratory infections, addictions, physical and emotional load.
Originating in childhood, the disease passesthrough life, degrading its quality, and often leads to another young man early disability. For patients with bronchial asthma is characterized by wheezing, occasionally audible even at a distance; nonproductive cough; constant shortness of breath during physical activity; night of suffocation caused by obstruction of the air entering the lungs.
Currently, medical treatmentasthma used two types of drugs: drugs for emergency relief, which act quickly, arresting caused symptoms or attack, and prevention of long-acting drugs that prevent development of the disease and thus help to control the condition.
Unfortunately, as demonstrated by long-term practice,treated asthma is difficult, drug therapy is often ineffective or inefficient. The drugs for the treatment of asthma is not aimed at eliminating the causes of the disease and the withdrawal of attacks and their prevention. That is why so much attention is paid to doctors prevent attacks, and primarily non-medical means.
Innovation among non-pharmaceutical products fortreatment of asthma and other chronic respiratory diseases is the emergence of "Aster" unit. "Aster" - is a unique drug-free formulation designed for individual use. The uniqueness of the device is that it treats is asthma, rather than its symptoms. "Aster" was developed in Russia, was fully certified and complies with the most stringent international safety standards, making it suitable for both adults and children from 1 year.
"Aster" The device is specially designed for use at home - it is light, compact, easy to operate, allowing them to use even for children without assistance.
The main indications for the use of "Aster" unit are:
- diagnosis of asthma of all degrees of severity;
- chronic obstructive pulmonary disease,
- prolonged bronchitis and laryngitis
- residual effects of pneumonia
Apparatus "Aster" is intended to optimize the function of the respiratory system in its violation due to allergic reactions of the body and transferred infectious respiratory diseases.
Application Aster apparatus contributes to:
- Facilitate breathing, improve sputum discharge when coughing;
- Reducing the number of daytime and nighttime asthma attacks;
- Reduce the pill burden;
- Reduction of terms of treatment of exacerbations and reduce the risk of subsequent relapses;
- The offensive stable remission and improved quality of life;
Despite, the fact that the machine is "Aster" is created forhome use, it is widely used in specialized clinics. Studies have shown that the use of the device for clinics reduces the presence of patients in the hospital by 40% and reduces the cost of treatment of diseases of the respiratory system by an average of 30%.
The duration of the treatment course unit"Aster" is defined by the source and the current condition of the patient. In the long history of the disease (over 5 years) the minimum duration of the course is 2.5 - 3 months. In the case of the long history of the disease and the application of patients hormonal therapy, after 5-7 days of daily use of the machine, "Aster", recommended focusing on the condition of the patient, gradually reduce the dose of hormones, until their complete abolition.
The average length of a session is 7-12 minutes. Conduct regular treatment sessions should be in the morning and evening from 7 to 10 hours.
The time interval between two sessions mustbe not less than 10 hours, since the benefits of the use of the device through a smaller amount of time will be less effective. Thus, during the day it is recommended not more than two sessions.
As a preventative measure, even ifreduction or absence of asthma symptoms it is recommended to use the product "Aster" and in between bouts. In such cases, it recommended to spend sessions lasting 8-10 minutes in the morning or the evening once in 1-2 days during 2,5 - 3 weeks prior to the seasonal exacerbation of the disease.
The therapeutic effect of "Aster" unit achievedby exposure to ultra-low flow thermal intensity of electromagnetic radiation on the area of "pulmonary triangle" of the human body. electromagnetic radiation parameters correspond to the most stringent safety standards.
Clinical studies have shown thatUse in pediatric practice "Aster" unit has significantly reduced the amount of medication for respiratory diseases and prevent unwanted side effects from the medication. In complex respiratory therapy device "Aster" reduces the level of early childhood disability, to reduce child mortality in respiratory pathology.
In the complex treatment regimens respiratory organsAdult health care facilities through the use of "Aster" device significantly reduces the treatment of these diseases, increases efficiency.
According to responses of patients, the use of"Aster" unit contributes to the disappearance of complications of asthma in the spring and autumn period. Most patients reported that the attacks took place the night choking back a normal sleep, decreased intake of medicines and hormones, or there is a complete rejection of them. The use of "Aster" unit has allowed patients with bronchial asthma to return to a full and active life.